549 related articles for article (PubMed ID: 14988248)
1. Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: clinical pathophysiology and natural history of beta-cell dysfunction and insulin resistance.
Mauvais-Jarvis F; Sobngwi E; Porcher R; Riveline JP; Kevorkian JP; Vaisse C; Charpentier G; Guillausseau PJ; Vexiau P; Gautier JF
Diabetes; 2004 Mar; 53(3):645-53. PubMed ID: 14988248
[TBL] [Abstract][Full Text] [Related]
2. Ketosis-prone atypical diabetes in Cameroonian people with hyperglycaemic crisis: frequency, clinical and metabolic phenotypes.
Lontchi-Yimagou E; Nguewa JL; Assah F; Noubiap JJ; Boudou P; Djahmeni E; Balti EV; Atogho-Tiedeu B; Gautier JF; Mbanya JC; Sobngwi E
Diabet Med; 2017 Mar; 34(3):426-431. PubMed ID: 27657549
[TBL] [Abstract][Full Text] [Related]
3. Effects of intravenous glucose load on insulin secretion in patients with ketosis-prone diabetes during near-normoglycemia remission.
Gosmanov AR; Smiley D; Robalino G; Siqueira JM; Peng L; Kitabchi AE; Umpierrez GE
Diabetes Care; 2010 Apr; 33(4):854-60. PubMed ID: 20067967
[TBL] [Abstract][Full Text] [Related]
4. Re: A comparison of classification schemes for ketosis-prone diabetes.
Nalini R; Maldonado M; Balasubramanyam A
Nat Clin Pract Endocrinol Metab; 2007 Dec; 3(12):E1. PubMed ID: 18026157
[No Abstract] [Full Text] [Related]
5. Changes in circulating adiponectin, leptin, glucose and C-peptide in patients with ketosis-prone diabetes.
Gupta P; Liu Y; Lapointe M; Yotsapon T; Sarat S; Cianflone K
Diabet Med; 2015 May; 32(5):692-700. PubMed ID: 25407468
[TBL] [Abstract][Full Text] [Related]
6. Ketosis-Prone Diabetes (Flatbush Diabetes): an Emerging Worldwide Clinically Important Entity.
Lebovitz HE; Banerji MA
Curr Diab Rep; 2018 Oct; 18(11):120. PubMed ID: 30280274
[TBL] [Abstract][Full Text] [Related]
7. [The classification and prognostic implication of islet β cell function before and in remission period in newly diagnosed diabetic patients with ketosis].
Fan H; Zhang PR; Liu J; Xu Y
Zhonghua Nei Ke Za Zhi; 2012 Feb; 51(2):108-13. PubMed ID: 22490810
[TBL] [Abstract][Full Text] [Related]
8. Ketosis-prone type 2 diabetes mellitus and human herpesvirus 8 infection in sub-saharan africans.
Sobngwi E; Choukem SP; Agbalika F; Blondeau B; Fetita LS; Lebbe C; Thiam D; Cattan P; Larghero J; Foufelle F; Ferre P; Vexiau P; Calvo F; Gautier JF
JAMA; 2008 Jun; 299(23):2770-6. PubMed ID: 18560004
[TBL] [Abstract][Full Text] [Related]
9. The interrelationship between insulin secretion and action in type 2 diabetes mellitus with different degrees of obesity: evidence supporting central obesity.
Duman BS; Turkoglu C; Gunay D; Cagatay P; Demiroglu C; Buyukdevrim AS
Diabetes Nutr Metab; 2003 Aug; 16(4):243-50. PubMed ID: 14768774
[TBL] [Abstract][Full Text] [Related]
10. Pathophysiology of insulin secretion in diabetes mellitus.
Ward WK; Beard JC; Halter JB; Porte D
Adv Exp Med Biol; 1985; 189():137-58. PubMed ID: 3898762
[TBL] [Abstract][Full Text] [Related]
11. [The natural history of diabetes with respect to disorders of insulin function].
Dorner M; Pinget M; Brogard JM; Sapin R; Paris-Bockel D; Levy P; Jung C
Journ Annu Diabetol Hotel Dieu; 1984; ():51-71. PubMed ID: 6399540
[No Abstract] [Full Text] [Related]
12. Should diabetic ketosis without acidosis be included in ketosis-prone type 2 diabetes mellitus?
Xie XJ; Hu Y; Cheng C; Feng TT; He K; Mao XM
Diabetes Metab Res Rev; 2014 Jan; 30(1):54-9. PubMed ID: 24038858
[TBL] [Abstract][Full Text] [Related]
13. Is type 2 diabetes a different disease in obese and nonobese patients?
Prando R; Cheli V; Melga P; Giusti R; Ciuchi E; Odetti P
Diabetes Care; 1998 Oct; 21(10):1680-5. PubMed ID: 9773730
[TBL] [Abstract][Full Text] [Related]
14. Pathophysiological study of the non-insulin-dependent phase of type I diabetes mellitus.
Torella R; Salvatore T; Cozzolino D; Grandillo F; Giugliano D
Acta Diabetol Lat; 1988; 25(2):161-72. PubMed ID: 3146849
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with insulin discontinuation in subjects with ketosis-prone diabetes but preserved beta-cell function.
Maldonado MR; Otiniano ME; Cheema F; Rodriguez L; Balasubramanyam A
Diabet Med; 2005 Dec; 22(12):1744-50. PubMed ID: 16401322
[TBL] [Abstract][Full Text] [Related]
16. Examining the effects of hyperglycemia on pancreatic endocrine function in humans: evidence for in vivo glucotoxicity.
Solomon TP; Knudsen SH; Karstoft K; Winding K; Holst JJ; Pedersen BK
J Clin Endocrinol Metab; 2012 Dec; 97(12):4682-91. PubMed ID: 23043193
[TBL] [Abstract][Full Text] [Related]
17. Comparison of type 1, type 2, and atypical ketosis-prone diabetes at 4 years of diabetes duration.
Ramos-Román MA; Piñero-Piloña A; Adams-Huet B; Raskin P
J Diabetes Complications; 2006; 20(3):137-44. PubMed ID: 16632232
[TBL] [Abstract][Full Text] [Related]
18. Ketosis-prone type 2 diabetes: effect of hyperglycemia on beta-cell function and skeletal muscle insulin signaling.
Umpierrez GE; Smiley D; Gosmanov A; Thomason D
Endocr Pract; 2007; 13(3):283-90. PubMed ID: 17599861
[TBL] [Abstract][Full Text] [Related]
19. [Obesity and diabetes].
Genes SG
Ter Arkh; 1974; 46(10):56-65. PubMed ID: 4610864
[No Abstract] [Full Text] [Related]
20. Characterization of beta-cell function impairment in first-degree relatives of type 2 diabetic subjects: modeling analysis of 24-h triple-meal tests.
Mari A; Gastaldelli A; Natali A; Ostergard T; Schmitz O; Ferrannini E
Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E541-6. PubMed ID: 15522997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
